Comment from Par Sterile Products, LLC

Summary: Par Sterile Products, LLC, represented by legal counsel Latham & Watkins LLP, opposes the nomination of vasopressin to the 503B Bulks List. They argue that the nomination lacks sufficient evidence of clinical need, poses significant safety risks, and seeks to facilitate the compounding of an "essentially a copy" of an FDA-approved drug.